A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.
This study has been completed.
First Posted: January 25, 2008
Last Update Posted: November 9, 2017
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||April 2009|
|Primary Completion Date:||April 2009 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Submission:||March 17, 2010|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Hesketh PJ, Wright O, Rosati G, Russo M, Levin J, Lane S, Moiseyenko V, Dube P, Kopp M, Makhson A. Single-dose intravenous casopitant in combination with ondansetron and dexamethasone for the prevention of oxaliplatin-induced nausea and vomiting: a multicenter, randomized, double-blind, active-controlled, two arm, parallel group study. Support Care Cancer. 2012 Jul;20(7):1471-8. doi: 10.1007/s00520-011-1235-4. Epub 2011 Aug 7.